Malar J

Malaria misdiagnosis in Uganda--implications for policy change.Nankabirwa J, Zurovac D, Njogu JN, Rwakimari JB, Counihan H, Snow RW, Tibenderana JK
Malar J, (2009). 8:66

Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity.Okiro EA, Al-Taiar A, Reyburn H, Idro R, Berkley JA, Snow RW
Malar J, (2009). 8:4

Costs and consequences of large-scale vector control for malaria.Yukich JO, Lengeler C, Tediosi F, Brown N, Mulligan JA, Chavasse D, Stevens W, Justino J, Conteh L, Maharaj R, Erskine M, Mueller DH, Wiseman V, Ghebremeskel T, Zerom M, Goodman C, McGuire D, Urrutia JM, Sakho F, Hanson K, Sharp B
Malar J, (2008). 7:258

Survival and haematological recovery of children with severe malaria transfused in accordance to WHO guidelines in Kilifi, Kenya.Akech SO, Hassall O, Pamba A, Idro R, Williams TN, Newton CR, Maitland K
Malar J, (2008). 7:256

The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence.Premji ZG, Abdulla S, Ogutu B, Ndong A, Falade CO, Sagara I, Mulure N, Nwaiwu O, Kokwaro G
Malar J, (2008). 7:244

Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia.Teka H, Petros B, Yamuah L, Tesfaye G, Elhassan I, Muchohi S, Kokwaro G, Aseffa A, Engers H
Malar J, (2008). 7:220

Human population, urban settlement patterns and their impact on Plasmodium falciparum malaria endemicity.Tatem AJ, Guerra CA, Kabaria CW, Noor AM, Hay SI
Malar J, (2008). 7:218

Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya.Temperley M, Mueller DH, Njagi JK, Akhwale W, Clarke SE, Jukes MC, Estambale BB, Brooker S
Malar J, (2008). 7:196

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.Zurovac D, Tibenderana JK, Nankabirwa J, Ssekitooleko J, Njogu JN, Rwakimari JB, Meek S, Talisuna A, Snow RW
Malar J, (2008). 7:181

Spatial prediction of Plasmodium falciparum prevalence in Somalia.Noor AM, Clements AC, Gething PW, Moloney G, Borle M, Shewchuk T, Hay SI, Snow RW
Malar J, (2008). 7:159

Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1.Mackintosh CL, Christodoulou Z, Mwangi TW, Kortok M, Pinches R, Williams TN, Marsh K, Newbold CI
Malar J, (2008). 7:155

Host choice and multiple blood feeding behaviour of malaria vectors and other anophelines in Mwea rice scheme, Kenya.Muriu SM, Muturi EJ, Shililu JI, Mbogo CM, Mwangangi JM, Jacob BG, Irungu LW, Mukabana RW, Githure JI, Novak RJ
Malar J, (2008). 7:43

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.Wasunna B, Zurovac D, Goodman CA, Snow RW
Malar J, (2008). 7:29

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.Sipilanyambe N, Simon JL, Chanda P, Olumese P, Snow RW, Hamer DH
Malar J, (2008). 7:25

The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania.Njau JD, Goodman CA, Kachur SP, Mulligan J, Munkondya JS, McHomvu N, Abdulla S, Bloland P, Mills A
Malar J, (2008). 7:4

The decline in paediatric malaria admissions on the coast of Kenya.Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, Peshu N, Marsh K, Snow RW
Malar J, (2007). 6:151

Incorporating a quiz into informed consent processes: qualitative study of participants' reactions.Molyneux S, Gikonyo C, Marsh V, Bejon P
Malar J, (2007). 6:145

Standardizing estimates of the Plasmodium falciparum parasite rate.Smith DL, Guerra CA, Snow RW, Hay SI
Malar J, (2007). 6:131

IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.Kinyanjui SM, Conway DJ, Lanar DE, Marsh K
Malar J, (2007). 6:82

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW
Malar J, (2007). 6:72